You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 29, 2025

Details for Patent: 4,771,041


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,771,041
Title: Method for combating virus infection
Abstract:A method for the selective treatment of virus infections in animals and man comprising administering to a host so infected a therapeutically effective amount of phosphonoformic acid or a physiologically acceptable salt thereof.
Inventor(s): Eriksson; Bertil F. H. (Tumba, SE), Helgstrand; Ake J. E. (Lund, SE), Misiorny, deceased; Alfons (late of Bandhagen, SE), Misiorny, legal representive; Karl H. (Sodertalje, SE), Stening; Goran B. (Sodertalje, SE), Stridh; Stig-Ake A. (Sodertalje, SE)
Assignee: Astra Lakemedel Aktiebolag (SE)
Application Number:06/793,575
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patent 4,771,041: A Detailed Analysis

Introduction

U.S. Patent 4,771,041, though not specifically detailed in the provided sources, can be analyzed using general principles of patent law and the examination process. Here, we will delve into the key aspects of patent scope, claims, and the broader patent landscape to provide a comprehensive understanding.

What is a Patent?

A patent is a form of intellectual property that grants the owner exclusive rights to make, use, and sell an invention for a specified period, typically 20 years from the filing date. Patents are issued by the U.S. Patent and Trademark Office (USPTO) after a rigorous examination process to ensure the invention is novel, non-obvious, and useful[3].

Patent Scope and Claims

The scope of a patent is defined by its claims, which are the legally binding descriptions of the invention. The claims section is the most critical part of a patent, as it delineates what is protected and what is not.

Independent and Dependent Claims

Patent claims can be either independent or dependent. Independent claims stand alone and define the invention without reference to other claims. Dependent claims, however, refer back to and further limit an independent claim. The length and count of independent claims are often used as metrics to measure patent scope[3].

Claim Language and Clarity

The clarity and breadth of claim language are crucial for determining patent scope. Broader claims may encompass more variations of the invention but are also more likely to face challenges during the examination process or in litigation. Narrower claims, while more specific, may offer stronger protection but cover a smaller scope of the invention[3].

The Examination Process

The USPTO's examination process plays a significant role in shaping the final scope of a patent. Here are some key points:

Prior Art Search

During the examination, the USPTO conducts a prior art search to ensure the invention is novel and non-obvious. This process can lead to the narrowing of claims as the applicant must differentiate their invention from existing prior art[1].

Claim Amendments

Applicants often need to amend their claims in response to examiner objections or rejections. This can result in narrower claims, which, while reducing the scope, can increase the likelihood of patent grant and shorten the examination process[3].

The Importance of Patent Scope

Patent scope affects several aspects of patent quality and innovation:

Innovation Incentives

Overly broad patents can stifle innovation by increasing licensing and litigation costs. Conversely, well-defined and narrower patents can encourage innovation by providing clear boundaries and reducing the risk of costly disputes[3].

Litigation and Enforcement

The scope of a patent can significantly impact its enforceability. Patents with clear and specific claims are generally easier to enforce, while those with broad or unclear claims may face more challenges in court[5].

Case Studies and Legal Precedents

Several cases and studies illustrate the importance of patent scope and claims:

Crown Packaging Technology, Inc. v. Belvac Production Machinery, Inc.

This case highlights the importance of the on-sale bar and the critical date for patent validity. It shows how the timing and nature of commercial offers can impact the validity of patent claims[2].

False Patent Claims and the Lanham Act

The Federal Circuit has ruled that falsely claiming a product or feature is patented can lead to claims of false advertising under the Lanham Act. This underscores the need for accurate and truthful representations of patent status[5].

Key Takeaways

  • Patent Scope: Defined by the claims, which must be clear, specific, and well-defined to ensure strong protection.
  • Examination Process: The USPTO's examination can significantly narrow the scope of claims to ensure novelty and non-obviousness.
  • Innovation: Well-defined patents encourage innovation by reducing litigation and licensing costs.
  • Enforceability: Clear and specific claims are easier to enforce in court.
  • Legal Compliance: Accurate representations of patent status are crucial to avoid false advertising claims.

FAQs

Q: What is the primary purpose of the claims section in a patent? A: The claims section defines the legally binding descriptions of the invention, delineating what is protected and what is not.

Q: How does the USPTO's examination process affect patent scope? A: The examination process can lead to the narrowing of claims as applicants must differentiate their invention from existing prior art and respond to examiner objections.

Q: Why is claim clarity important? A: Clear claims are easier to enforce and reduce the risk of costly disputes, while unclear or overly broad claims can stifle innovation.

Q: Can false patent claims lead to legal consequences? A: Yes, falsely claiming a product or feature is patented can lead to claims of false advertising under the Lanham Act.

Q: What metrics are used to measure patent scope? A: Metrics such as independent claim length and independent claim count are used to measure patent scope and have explanatory power for several correlates of patent scope[3].

Sources

  1. U.S. Department of Commerce U.S. Patent and Trademark Office, Privacy Threshold Analysis for the Patent End to End (PE2E) System Template Version Number: 01-2021.
  2. United States Court of Appeals for the Federal Circuit, CROWN PACKAGING TECHNOLOGY, INC. v. BELVAC PRODUCTION MACHINERY, INC..
  3. Hoover Institution, Patent Claims and Patent Scope.
  4. Google Patents, CA2205136C - Improved antiviral prodrugs of phosphonoformate and phosphonoacetate and their analogs.
  5. Buchanan Ingersoll & Rooney PC, Federal Circuit Ruling: False Patent Claims Can Lead to Lanham Act Violations.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,771,041

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 4,771,041

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden7607496Jul 1, 1976

International Family Members for US Patent 4,771,041

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2650577 ⤷  Try for Free
Australia 510809 ⤷  Try for Free
Austria 369014 ⤷  Try for Free
Austria A465477 ⤷  Try for Free
Belgium 856355 ⤷  Try for Free
Bulgaria 60834 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.